Abnib 250mg Tablet
Abnib 250mg Tablet is used in the treatment of breast cancer. It works by stopping or slowing down the growth of cancer cells. It is either used alone or in combination with some other medicine to cure advanced-stage breast cancer.
Abnib 250mg Tablet
Basic Information
Important information about this medicine
About This Medicine
General information about this product
Abnib 250mg Tablet is used in the treatment of breast cancer. It works by stopping or slowing down the growth of cancer cells. It is either used alone or in combination with some other medicine to cure advanced-stage breast cancer.
Abnib 250mg Tablet is used in the treatment of breast cancer. It works by stopping or slowing down the growth of cancer cells. It is either used alone or in combination with some other medicine to cure advanced-stage breast cancer.
Abnib 250mg Tablet should be taken on an empty stomach or an hour before or 2 hours after a meal. The dose and duration vary according to the severity of your condition and your response to treatment. Take it exactly as prescribed to avoid serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.The most common side effects of this medicine include nausea, headache, back pain, and breathing difficulty. It may cause severe diarrhea, drink plenty of fluids or consult with your doctor if it bothers you. You may be asked for regular monitoring of blood pressure while taking this medicine. Inform your doctor if you notice a severe headache, confusion, problems with your eyesight, nausea, or vomiting. Your doctor may check your liver function before, during, and after treatment with this medicine.Before taking
Abnib 250mg Tablet, let your doctor know if you have liver or kidney problems. Many other medicines can affect, or be affected by, this medicine so let your healthcare team know all medications you are taking. This medicine is not recommended during pregnancy or while breastfeeding. The use of effective contraception by both males and females during treatment is important to avoid pregnancy.
03Uses
Breast cancer
04How To Use
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Abnib 250mg Tablet is to be taken empty stomach.
05How It Works
Abnib 250mg Tablet is an anti-cancer medication. It works against the HER2 (human epidermal growth factor receptor protein) receptors and EGFRs (epidermal growth factor receptor) which are responsible for the over-proliferation of cells. This is how it inhibits the growth of cancerous cells causing downstream signaling pathways.
06What If You Miss A Dose?
If you miss a dose of Abnib 250mg Tablet, consult your doctor.
07Benefits
In Breast cancer
Abnib 250mg Tablet helps to treat breast cancer and it may be used alone or in combination with other medicines or treatment modalities like chemotherapy. It relieves the symptoms of breast cancer such as breast lumps, bloody discharge from nipples or changes in the shape or texture of the breast. Abnib 250mg Tablet kills or stops the growth of cancer cells and also prevents the multiplication of cancer cells. Discuss with your doctor if any of the side effects bother you.
08Side Effects
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Weight gain
Weakness
Vomiting
Stomatitis (Inflammation of the mouth)
Rash
Pain in extremity
Nausea
Mucosal inflammation
Loss of appetite
Liver damage
Joint pain
Insomnia (difficulty in sleeping)
Increased bilirubin in the blood
Hot flashes
Headache
Fatigue
Diarrhea
Cough
Constipation
Breathing problems
Back pain
Abdominal pain
09Safety Information
Alcohol:CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Abnib 250mg Tablet. Please consult your doctor.
Pregnancy:CONSULT YOUR DOCTOR
Abnib 250mg Tablet is unsafe to use during pregnancy as there is definite evidence of risk to the developing baby. However, the doctor may rarely prescribe it in some life-threatening situations if the benefits are more than the potential risks. Please consult your doctor.
Breast feeding:UNSAFE
Abnib 250mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Driving:UNSAFE
Abnib 250mg Tablet may cause side effects which could affect your ability to drive.
Kidney:CAUTION
Abnib 250mg Tablet should be used with caution in patients with severe kidney disease. Dose adjustment of Abnib 250mg Tablet may be needed. Please consult your doctor.Limited information is available on the use of Abnib 250mg Tablet in these patients. No dose adjustment is recommended in patients with mild to moderate kidney disease.
Liver:CAUTION
Abnib 250mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Abnib 250mg Tablet may be needed. Please consult your doctor.Limited information is available on the use of this medicine in patients with the severe liver disease.
10Drug Tips
It should be taken 1 hour before or 2 hours after the meal, preferably at the same time every day.
Diarrhea may occur as a side effect. Drink plenty of fluids and inform your doctor if it doesn’t stop or if you find blood in your stools.
Use a reliable contraceptive method to prevent pregnancy while you are taking this medicine and for a month after you stop taking it.
Monitor your blood pressure regularly while taking this medication. Inform your doctor if you notice symptoms of very high blood pressure such as severe headache, confusion, problems with your eyesight, nausea or vomiting.
It may cause serious bleeding problem. Inform your doctor if you get headaches, stomach pain or if you notice blood in your urine or stools.
Do not take this medicine if you are pregnant, planning to conceive or breastfeeding.
References
Sources and references
Chabner BA, Barnes J, Neal J, et al. Targeted Therapies: Tyrosine Kinase Inhibitors, Monoclonal Antibodies, and Cytokines. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1737-38.
Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 779-80.
Lapatinib ditosylate monohydrate. Camberley, Surrey: Novartis Pharmaceuticals UK Ltd.; 2008 . view
Lapatinib. Research Triangle Park, North Carolina: GlaxoSmithKline; 2007 . view
Drugs and Lactation Database. Bethesda : National Library of Medicine ; 2006. Lapatinib. . view
Central Drugs Standard Control Organisation . view
